bis(N-tert-butyl-N,1-dimethylpiperidin-4-amine);N-tert-butyl-N-methylcyclohexanamine;bis(1-(3,3-dimethylbutyl)-4-methylpiperazine);bis(2-methyl-N-[(1-methylpiperidin-4-yl)methyl]propan-2-amine);tris(1-methyl-4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazine);1-methyl-4-[(2-methylpropan-2-yl)oxymethyl]piperidine;4-[2-[(2-methylpropan-2-yl)oxy]ethyl]morpholine

C131H283N21O6 — CID 162254840

IUPACbis(N-tert-butyl-N,1-dimethylpiperidin-4-amine);N-tert-butyl-N-methylcyclohexanamine;bis(1-(3,3-dimethylbutyl)-4-methylpiperazine);bis(2-methyl-N-[(1-methylpiperidin-4-yl)methyl]propan-2-amine);tris(1-methyl-4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazine);1-methyl-4-[(2-methylpropan-2-yl)oxymethyl]piperidine;4-[2-[(2-methylpropan-2-yl)oxy]ethyl]morpholine
SMILESCC(C)(C)OCCN1CCOCC1.CN(C1CCCCC1)C(C)(C)C.CN1CCC(CNC(C)(C)C)CC1.CN1CCC(CNC(C)(C)C)CC1.CN1CCC(COC(C)(C)C)CC1.CN1CCC(N(C)C(C)(C)C)CC1.CN1CCC(N(C)C(C)(C)C)CC1.CN1CCN(CCC(C)(C)C)CC1.CN1CCN(CCC(C)(C)C)CC1.CN1CCN(CCOC(C)(C)C)CC1.CN1CCN(CCOC(C)(C)C)CC1.CN1CCN(CCOC(C)(C)C)CC1
InChIInChI=1S/3C11H24N2O.6C11H24N2.C11H23NO.C11H23N.C10H21NO2/c3*1-11(2,3)14-10-9-13-7-5-12(4)6-8-13;2*1-11(2,3)13(5)10-6-8-12(4)9-7-10;2*1-11(2,3)12-9-10-5-7-13(4)8-6-10;2*1-11(2,3)5-6-13-9-7-12(4)8-10-13;1-11(2,3)13-9-10-5-7-12(4)8-6-10;1-11(2,3)12(4)10-8-6-5-7-9-10;1-10(2,3)13-9-6-11-4-7-12-8-5-11/h3*5-10H2,1-4H3;2*10H,6-9H2,1-5H3;2*10,12H,5-9H2,1-4H3;2*5-10H2,1-4H3;10H,5-9H2,1-4H3;10H,5-9H2,1-4H3;4-9H2,1-3H3
InChIKeyZYLMUPLCJQGYGE-UHFFFAOYSA-N
MW2248.85 g/mol
LogP19.87
Rot. Bonds25

About bis(N-tert-butyl-N,1-dimethylpiperidin-4-amine);N-tert-butyl-N-methylcyclohexanamine;bis(1-(3,3-dimethylbutyl)-4-methylpiperazine);bis(2-methyl-N-[(1-methylpiperidin-4-yl)methyl]propan-2-amine);tris(1-methyl-4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazine);1-methyl-4-[(2-methylpropan-2-yl)oxymethyl]piperidine;4-[2-[(2-methylpropan-2-yl)oxy]ethyl]morpholine

bis(N-tert-butyl-N,1-dimethylpiperidin-4-amine);N-tert-butyl-N-methylcyclohexanamine;bis(1-(3,3-dimethylbutyl)-4-methylpiperazine);bis(2-methyl-N-[(1-methylpiperidin-4-yl)methyl]propan-2-amine);tris(1-methyl-4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazine);1-methyl-4-[(2-methylpropan-2-yl)oxymethyl]piperidine;4-[2-[(2-methylpropan-2-yl)oxy]ethyl]morpholine (PubChem CID 162254840) has the molecular formula C131H283N21O6 and a molecular weight of 2248.85 g/mol. Its IUPAC name is bis(N-tert-butyl-N,1-dimethylpiperidin-4-amine);N-tert-butyl-N-methylcyclohexanamine;bis(1-(3,3-dimethylbutyl)-4-methylpiperazine);bis(2-methyl-N-[(1-methylpiperidin-4-yl)methyl]propan-2-amine);tris(1-methyl-4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazine);1-methyl-4-[(2-methylpropan-2-yl)oxymethyl]piperidine;4-[2-[(2-methylpropan-2-yl)oxy]ethyl]morpholine.

Molecular Properties

Compound Namebis(N-tert-butyl-N,1-dimethylpiperidin-4-amine);N-tert-butyl-N-methylcyclohexanamine;bis(1-(3,3-dimethylbutyl)-4-methylpiperazine);bis(2-methyl-N-[(1-methylpiperidin-4-yl)methyl]propan-2-amine);tris(1-methyl-4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazine);1-methyl-4-[(2-methylpropan-2-yl)oxymethyl]piperidine;4-[2-[(2-methylpropan-2-yl)oxy]ethyl]morpholine
PubChem CID162254840
Molecular FormulaC131H283N21O6
Molecular Weight2248.85 g/mol
Exact Mass2247.25
IUPAC Namebis(N-tert-butyl-N,1-dimethylpiperidin-4-amine);N-tert-butyl-N-methylcyclohexanamine;bis(1-(3,3-dimethylbutyl)-4-methylpiperazine);bis(2-methyl-N-[(1-methylpiperidin-4-yl)methyl]propan-2-amine);tris(1-methyl-4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazine);1-methyl-4-[(2-methylpropan-2-yl)oxymethyl]piperidine;4-[2-[(2-methylpropan-2-yl)oxy]ethyl]morpholine
SMILESCC(C)(C)OCCN1CCOCC1.CN(C1CCCCC1)C(C)(C)C.CN1CCC(CNC(C)(C)C)CC1.CN1CCC(CNC(C)(C)C)CC1.CN1CCC(COC(C)(C)C)CC1.CN1CCC(N(C)C(C)(C)C)CC1.CN1CCC(N(C)C(C)(C)C)CC1.CN1CCN(CCC(C)(C)C)CC1.CN1CCN(CCC(C)(C)C)CC1.CN1CCN(CCOC(C)(C)C)CC1.CN1CCN(CCOC(C)(C)C)CC1.CN1CCN(CCOC(C)(C)C)CC1
InChIInChI=1S/3C11H24N2O.6C11H24N2.C11H23NO.C11H23N.C10H21NO2/c3*1-11(2,3)14-10-9-13-7-5-12(4)6-8-13;2*1-11(2,3)13(5)10-6-8-12(4)9-7-10;2*1-11(2,3)12-9-10-5-7-13(4)8-6-10;2*1-11(2,3)5-6-13-9-7-12(4)8-10-13;1-11(2,3)13-9-10-5-7-12(4)8-6-10;1-11(2,3)12(4)10-8-6-5-7-9-10;1-10(2,3)13-9-6-11-4-7-12-8-5-11/h3*5-10H2,1-4H3;2*10H,6-9H2,1-5H3;2*10,12H,5-9H2,1-4H3;2*5-10H2,1-4H3;10H,5-9H2,1-4H3;10H,5-9H2,1-4H3;4-9H2,1-3H3
InChIKeyZYLMUPLCJQGYGE-UHFFFAOYSA-N
XLogP19.87
TPSA141.00 Ų
H-Bond Donors2
H-Bond Acceptors27
Rotatable Bonds25
Heavy Atoms158
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002248.85
LogP ≤ 519.87
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1027

Analyze bis(N-tert-butyl-N,1-dimethylpiperidin-4-amine);N-tert-butyl-N-methylcyclohexanamine;bis(1-(3,3-dimethylbutyl)-4-methylpiperazine);bis(2-methyl-N-[(1-methylpiperidin-4-yl)methyl]propan-2-amine);tris(1-methyl-4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazine);1-methyl-4-[(2-methylpropan-2-yl)oxymethyl]piperidine;4-[2-[(2-methylpropan-2-yl)oxy]ethyl]morpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of bis(N-tert-butyl-N,1-dimethylpiperidin-4-amine);N-tert-butyl-N-methylcyclohexanamine;bis(1-(3,3-dimethylbutyl)-4-methylpiperazine);bis(2-methyl-N-[(1-methylpiperidin-4-yl)methyl]propan-2-amine);tris(1-methyl-4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazine);1-methyl-4-[(2-methylpropan-2-yl)oxymethyl]piperidine;4-[2-[(2-methylpropan-2-yl)oxy]ethyl]morpholine?
The IUPAC name of bis(N-tert-butyl-N,1-dimethylpiperidin-4-amine);N-tert-butyl-N-methylcyclohexanamine;bis(1-(3,3-dimethylbutyl)-4-methylpiperazine);bis(2-methyl-N-[(1-methylpiperidin-4-yl)methyl]propan-2-amine);tris(1-methyl-4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazine);1-methyl-4-[(2-methylpropan-2-yl)oxymethyl]piperidine;4-[2-[(2-methylpropan-2-yl)oxy]ethyl]morpholine (CID 162254840) is bis(N-tert-butyl-N,1-dimethylpiperidin-4-amine);N-tert-butyl-N-methylcyclohexanamine;bis(1-(3,3-dimethylbutyl)-4-methylpiperazine);bis(2-methyl-N-[(1-methylpiperidin-4-yl)methyl]propan-2-amine);tris(1-methyl-4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazine);1-methyl-4-[(2-methylpropan-2-yl)oxymethyl]piperidine;4-[2-[(2-methylpropan-2-yl)oxy]ethyl]morpholine.
What is the SMILES notation for bis(N-tert-butyl-N,1-dimethylpiperidin-4-amine);N-tert-butyl-N-methylcyclohexanamine;bis(1-(3,3-dimethylbutyl)-4-methylpiperazine);bis(2-methyl-N-[(1-methylpiperidin-4-yl)methyl]propan-2-amine);tris(1-methyl-4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazine);1-methyl-4-[(2-methylpropan-2-yl)oxymethyl]piperidine;4-[2-[(2-methylpropan-2-yl)oxy]ethyl]morpholine?
The canonical SMILES for bis(N-tert-butyl-N,1-dimethylpiperidin-4-amine);N-tert-butyl-N-methylcyclohexanamine;bis(1-(3,3-dimethylbutyl)-4-methylpiperazine);bis(2-methyl-N-[(1-methylpiperidin-4-yl)methyl]propan-2-amine);tris(1-methyl-4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazine);1-methyl-4-[(2-methylpropan-2-yl)oxymethyl]piperidine;4-[2-[(2-methylpropan-2-yl)oxy]ethyl]morpholine is CC(C)(C)OCCN1CCOCC1.CN(C1CCCCC1)C(C)(C)C.CN1CCC(CNC(C)(C)C)CC1.CN1CCC(CNC(C)(C)C)CC1.CN1CCC(COC(C)(C)C)CC1.CN1CCC(N(C)C(C)(C)C)CC1.CN1CCC(N(C)C(C)(C)C)CC1.CN1CCN(CCC(C)(C)C)CC1.CN1CCN(CCC(C)(C)C)CC1.CN1CCN(CCOC(C)(C)C)CC1.CN1CCN(CCOC(C)(C)C)CC1.CN1CCN(CCOC(C)(C)C)CC1.
What is the InChIKey of bis(N-tert-butyl-N,1-dimethylpiperidin-4-amine);N-tert-butyl-N-methylcyclohexanamine;bis(1-(3,3-dimethylbutyl)-4-methylpiperazine);bis(2-methyl-N-[(1-methylpiperidin-4-yl)methyl]propan-2-amine);tris(1-methyl-4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazine);1-methyl-4-[(2-methylpropan-2-yl)oxymethyl]piperidine;4-[2-[(2-methylpropan-2-yl)oxy]ethyl]morpholine?
The InChIKey is ZYLMUPLCJQGYGE-UHFFFAOYSA-N. The full InChI is InChI=1S/3C11H24N2O.6C11H24N2.C11H23NO.C11H23N.C10H21NO2/c3*1-11(2,3)14-10-9-13-7-5-12(4)6-8-13;2*1-11(2,3)13(5)10-6-8-12(4)9-7-10;2*1-11(2,3)12-9-10-5-7-13(4)8-6-10;2*1-11(2,3)5-6-13-9-7-12(4)8-10-13;1-11(2,3)13-9-10-5-7-12(4)8-6-10;1-11(2,3)12(4)10-8-6-5-7-9-10;1-10(2,3)13-9-6-11-4-7-12-8-5-11/h3*5-10H2,1-4H3;2*10H,6-9H2,1-5H3;2*10,12H,5-9H2,1-4H3;2*5-10H2,1-4H3;10H,5-9H2,1-4H3;10H,5-9H2,1-4H3;4-9H2,1-3H3.
What are the key properties of bis(N-tert-butyl-N,1-dimethylpiperidin-4-amine);N-tert-butyl-N-methylcyclohexanamine;bis(1-(3,3-dimethylbutyl)-4-methylpiperazine);bis(2-methyl-N-[(1-methylpiperidin-4-yl)methyl]propan-2-amine);tris(1-methyl-4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazine);1-methyl-4-[(2-methylpropan-2-yl)oxymethyl]piperidine;4-[2-[(2-methylpropan-2-yl)oxy]ethyl]morpholine?
bis(N-tert-butyl-N,1-dimethylpiperidin-4-amine);N-tert-butyl-N-methylcyclohexanamine;bis(1-(3,3-dimethylbutyl)-4-methylpiperazine);bis(2-methyl-N-[(1-methylpiperidin-4-yl)methyl]propan-2-amine);tris(1-methyl-4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazine);1-methyl-4-[(2-methylpropan-2-yl)oxymethyl]piperidine;4-[2-[(2-methylpropan-2-yl)oxy]ethyl]morpholine has a molecular weight of 2248.85 g/mol, XLogP of 19.87, 25 rotatable bonds, 2 hydrogen bond donors, and 27 hydrogen bond acceptors.
Where does this data come from?
All data for bis(N-tert-butyl-N,1-dimethylpiperidin-4-amine);N-tert-butyl-N-methylcyclohexanamine;bis(1-(3,3-dimethylbutyl)-4-methylpiperazine);bis(2-methyl-N-[(1-methylpiperidin-4-yl)methyl]propan-2-amine);tris(1-methyl-4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazine);1-methyl-4-[(2-methylpropan-2-yl)oxymethyl]piperidine;4-[2-[(2-methylpropan-2-yl)oxy]ethyl]morpholine is sourced from PubChem (CID 162254840), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).